A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

NCT07183371 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL: R21
BIOLOGICAL: RH5.1
BIOLOGICAL: R78C
BIOLOGICAL: Matrix-M™
BIOLOGICAL: Rabivax-S
BIOLOGICAL: Menveo
BIOLOGICAL: Avaxim 80

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]